Symbol="RETA"
AssetType="Common Stock"
Name="Reata Pharmaceuticals Inc"
Description="Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops novel therapies for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cell metabolism and inflammation. The company is headquartered in Plano, Texas."
CIK="1358762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="5320 LEGACY DRIVE, PLANO, TX, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="6349942000"
EBITDA="-340537984"
PERatio="None"
PEGRatio="0"
BookValue="2.306"
DividendPerShare="0"
DividendYield="0"
EPS="-9.73"
RevenuePerShareTTM="0.635"
ProfitMargin="0"
OperatingMarginTTM="-14.55"
ReturnOnAssetsTTM="-0.377"
ReturnOnEquityTTM="-1.124"
RevenueTTM="23480000"
GrossProfitTTM="-167627000"
DilutedEPSTTM="-9.73"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="28.85"
AnalystTargetPrice="172.45"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="414.73"
PriceToBookRatio="285.94"
EVToRevenue="316.34"
EVToEBITDA="-3.746"
Beta="1.437"
num_52WeekHigh="169.75"
num_52WeekLow="20.02"
num_50DayMovingAverage="120.39"
num_200DayMovingAverage="77.03"
SharesOutstanding="33036100"
DividendDate="None"
ExDividendDate="None"
symbol="RETA"
open="168.80"
high="169.35"
low="168.63"
price="169.00"
volume="532468.00"
latest_trading_day="2023-08-17"
previous_close="169.06"
change="-0.06"
change_percent="-0.0355%"
aroon_positive_momentum_days="73"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Overbought"
value_analysis="Overvalued"
Aroon_change="FALSE"
Aroon_momentum="73"
Volume_recent_avg="900706"
Change_recent_avg="0.18"
Delta_recent_avg="3.93"
Variance_recent_avg="1.96"
Change_ratio_recent_avg="0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="73"
Aroon_momentum_negative="27"
image_negative_thumbnail_id_1="503"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0102.jpeg"
image_negative_thumbnail_id_2="1130"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0163.jpeg"
image_neutral_thumbnail_id_1="598"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="643"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0065.jpeg"
image_positive_thumbnail_id_2="1002"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0164.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
